Skip to main content

Peer Review reports

From: Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

Original Submission
18 Mar 2016 Submitted Original manuscript
6 Jul 2016 Reviewed Reviewer Report - Julien Péron
8 Feb 2017 Reviewed Reviewer Report - Gian Bertelli
8 Mar 2017 Author responded Author comments - Bernhard Pestalozzi
Resubmission - Version 2
8 Mar 2017 Submitted Manuscript version 2
Publishing
4 Apr 2017 Editorially accepted
13 Apr 2017 Article published 10.1186/s12885-017-3261-1

You can find further information about peer review here.

Back to article page